Moody's Investors Service said Tuesday the medical products and device sector is set for stable growth, though it may not fully recover to pre-recession levels.
"We foresee generally stable business fundamentals for the medical products and device sector over the next 12 months to 18 months," said Diana Lee, a Moody's senior credit officer.
The growth drivers and negative effects of the economy will vary by sub-sector, Moody's said. Hospital supply companies should be among the most resilient. Also, Moody's doesn't expect a significant decline in the growth of hospital admissions over the near-term, even though the extension of COBRA health benefits to the jobless is winding down.
New product launches should benefit medical device companies, along with a gradual recovery in equipment spending by hospitals, Moody's said.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology